BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report)’s stock price reached a new 52-week high during trading on Monday . The company traded as high as $1.74 and last traded at $1.69, with a volume of 10528 shares trading hands. The stock had previously closed at $1.65.
BioRestorative Therapies Price Performance
The stock’s 50-day moving average is $1.61 and its 200 day moving average is $1.55. The company has a market cap of $2.77 billion, a PE ratio of -1.54 and a beta of 102.36.
BioRestorative Therapies Company Profile
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
Further Reading
- Five stocks we like better than BioRestorative Therapies
- What Are Dividend Achievers? An Introduction
- Whirlpool’s High Dividend Yield Is Too Good to Pass Up
- CD Calculator: Certificate of Deposit Calculator
- Holiday Spending Boom Ahead: 3 BNPL Stocks Poised for Gains
- How to Plot Fibonacci Price Inflection Levels
- Boeing: A Perfect Storm of Trouble Is a Loaded Buying Opportunity
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
